# A Prospective Randomized Multicenter Trial of the Guidewire for Echo-guided Interventions

Study · id `cardio:ct-nct04096924` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04096924](<https://clinicaltrials.gov/study/NCT04096924>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04096924

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT04096924. Randomized; no masking; primary purpose treatment. Start 2018-07-07 (actual); primary completion 2019-12-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT04096924, source copy `cardio:ctgov-nct04096924-2019-09-20`, retrieved 2026-10-26)
- Started: 2018-07-07 (actual) (ClinicalTrials.gov record NCT04096924, source copy `cardio:ctgov-nct04096924-2019-09-20`, retrieved 2026-10-26)
- Primary completion: 2019-12-30 (anticipated) (ClinicalTrials.gov record NCT04096924, source copy `cardio:ctgov-nct04096924-2019-09-20`, retrieved 2026-10-26)
- Completion: 2020-05-30 (anticipated) (ClinicalTrials.gov record NCT04096924, source copy `cardio:ctgov-nct04096924-2019-09-20`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04096924, source copy `cardio:ctgov-nct04096924-2019-09-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04096924-2019-09-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Prospective Randomized Multicenter Trial of the Guidewire for Echo-guided Interventions
- Condition: Atrial Septal Defect
- Intervention (Device): Guidewire for echo-guided interventions
- Intervention (Device): Cook lunderquist guidewire
- Lead sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Congenital heart disease (`core:congenital-heart-disease`)
- Registry lists this organization as the lead sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital (`cardio:org-chinese-academy-of-medical-sciences-fuwai-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Novel Panna Guide Wire Facilitates Percutaneous and Nonfluoroscopic Procedure for Atrial Septal Defect Closure: A Randomized Controlled Trial (`cardio:pubmed-32847382`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 82a6ed2ac5198b881ce5b8aeac2833a7b3bc660de72b91f247b745f8ecbd4c27
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
